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Introduction
The overall annual incidence of gastric cancer in Korea is the 
highest among all cancers, and it has been reported that gastric 
cancer after lung cancer is the second major cause of cancer 
deaths in the country. Due to the directed efforts towards health 
examination and the development of endoscopic techniques, the 
incidence of early gastric cancer that was difficult to find in the past 
Frequency and Predictive Factors of Lymph 
Node Metastasis in Mucosal Cancer
Myung Jin Nam*, Seung Jong Oh*, Cheong Ah Oh, Dae Hoon Kim, Young Sik Bae, 
Min Gew Choi, Jae Hyung Noh, Tae Sung Sohn, Jae Moon Bae, and Sung Kim
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Purpose: The incidence of lymph node metastasis has been reported to range from 2.6 to 4.8% in early stage gastric cancer with muco-
sal invasion (T1a cancer). Lymph node metastasis in early stage gastric cancer is known as an important predictive factor. We analyzed 
the prediction factors of lymph node metastasis in T1a cancer.
Materials and Methods: A total of 9,912 patients underwent radical gastrectomy due to gastric cancer from October 1994 to July 2006 
in the Department Of Surgery at Samsung Medical Center. We did a retrospective analysis of 2,524 patients of these patients, ones for 
whom the cancer was confined within the mucosa. 
Results: Among the 2,524 patients, 57 (2.2%) were diagnosed with lymph node metastasis, and of these, cancer staging was as fol-
lows: 41 were N1, 8 were N2, and 8 were N3a. Univariate analysis of clinicopathological factors showed that the following factors were 
significant predictors of metastasis: tumor size larger than 4 cm, the presence of middle and lower stomach cancer, poorly differentiated 
adenocarcinoma and signet-ring cell carcinoma, diffuse type cancer (by the Lauren classification), and lymphatic invasion. Multivariate 
analysis showed that lymphatic invasion and tumor larger than 4 cm were significant factors with P<0.001 and P=0.024, respectively. 
Conclusions: The frequency of lymph node metastasis is extremely low in early gastric cancer with mucosal invasion. However, when 
lymphatic invasion is present or the tumor is larger than 4 cm, there is a greater likelihood of lymph node metastasis. In such cases, 
surgical treatments should be done to prevent disease recurrence. 
Key Words: Stomach neoplasms, Gastric mucosa, Lymphatic metastasis, Predisposing factor
J Gastric Cancer 2010;10(4):162-167 y DOI:10.5230/jgc.2010.10.4.162
Correspondence to: Jae Hyung Noh
Department of Surgery, Samsung Medical Center, Sungkyunkwan 
University School of Medicine, 50, Irwon-dong, Gangnam-gu, Seoul 
135-710, Korea 
Tel: +82-2-3410-0498, Fax: +82-2-3410-6981
E-mail: jhnoh@skku.edu
Received August 17, 2010
Accepted October 18, 2010
*The first authors are Myung Jin Nam and Seung Jong Oh.
has increased.(1) About 52% of gastric cancer surgeries undertaken 
in our hospital since 2002 were due to early gastric cancer, and 
according to the other studies carried out recently, approximately 
40% of all gastric cancer patients were diagnosed with early gastric 
cancer.(1,2) In Japan the incidence has been reported as more than 
50% of all gastric cancers.(3,4) 
Early gastric cancer, regardless of lymph node metastasis, 
refers to malignant tumors confined to the mucosa or submucosa, 
and the prognosis of these patients is very good compared to 
other malignant tumors.(1,5) According to previous studies on 
the prognostic factors of gastric cancer, the factors that affect the 
prognosis are patient age, tumor size and location, depth of invasion, 
grade of histologic differentiation, the degree of lymph node 
metastasis, distant metastasis, and curative surgery.(5-7) Especially 
with regards to early gastric cancer, lymph node metastasis as Nam MJ, et al.
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well as depth of invasion have been deemed the most important 
prognostic factors.(5-7) Typically, lymph node metastases are found 
in 10 to 15% of early gastric cancer cases, and if early gastric cancer 
is divided into mucosal cancer and submucosal cancer, it is known 
to be found in 2.6 to 4.6% of mucosal cancer and in 16.5 to 23.6% 
of submucosal cancer.(7-9) Due to the advances in endoscopic 
equipment and techniques, minimally invasive treatments such as 
endoscopic resection have been actively undertaken. Particularly in 
the case of early gastric cancer confined to mucosa, it is important 
to predict lymph node metastasis because the treatment is only 
completed by endoscopic resection. In case of mucosal cancer, the 
incidence of lymph node metastasis is very low. However, because 
it is an important prognostic factor for early gastric cancer, the 
research on the risk factors, that is, the predictive factors of lymph 
node metastasis has a significant role in selection of the treatment 
approach for mucosal cancer and providing the appropriate criteria 
for the follow-up observations. In this study, we attempted to 
identify the typical clinicopathological characteristics that appear in 
early gastric cancer confined to the mucosa, the incidence of lymph 
node metastasis, and the predictive factors for a target of a large 
group in the Medical Center. 
Materials and Methods
We conducted an analysis of 2,524 patients (25.46%) diagnosed 
with mucosal cancer upon histological examination among 9,912 
patients who underwent radical gastrectomy due to gastric cancer 
from October 1994 to July 2006 in the Department of Surgery, 
Samsung Medical Center, Sungkyunkwan University School of 
Medicine. With reference to the medical records and pathology 
reports, we investigated gender, age, tumor size and location, 
gross appearance, histologic differentiation, Lauren classification, 
lymphatic invasion, vascular invasion, perineural invasion and 
surgical methods, and performed a retrospective analysis about the 
correlations between each clinicopathological factors and lymph 
node metastasis. 
Among all of 2,524 patients, 1,616 (64.0%) were men, 908 
(36.0%) were women, and their median age was 53.6 (21~87 
years old). According to the tumor size, they were divided into 
four groups, i.e., less than 1 cm, 1~2 cm, 2~4 cm, 4 cm or more. 
Depending on the location of the primary tumor, they were divided 
into the upper stomach (upper third), the middle stomach (middle 
third), or the lower stomach (lower third). We used the classification 
of TNM staging published in 2010 by American Joint Committee 
for Cancer Stage, 7th edition, and lymph node dissection ranges 
were classified based on the agreement published by the Japanese 
Gastric Cancer Association.(10) The statistical analyses were carried 
out using SPSS for Windows (Ver. 17.0, SPSS Inc., Chicago, IL, 
USA). Clinicopathological prognostic factors were compared using 
Chi-square test and multivariate analysis was performed using Cox 
regression hazards model. The statistical significance was set at a 
value of P＜0.05. 
Results
1. Univariate analysis of clinicopathological factors 
associated with lymph node metastasis
Among total 2,524 patients, lymph node metastasis was found in 
57 patients (2.2%), and out of these 57 people, 41 were diagnosed 
with N1, 8 with N2 and 8 with N3a. Patient gender (male 54.4% 
vs. female 45.6%, P=0.127) and age (54.6 vs. 52.6 years old, 
P=0.207) were not related with lymph node metastasis. Lymph 
node metastases were found in 8 (3.17%) of 252 patients underwent 
radical total gastrectomy and 49 (2.16%) of the 2,272 patients 
underwent radical subtotal gastrectomy, but the result was not 
statistically significant (P=0.268).
The result of analysis depending on the size of the tumor 
revealed that lymph node metastasis was found in 2 (0.5%) of 360 
patients with less than 1 cm, 8 (1.2%) of 645 patients with 1~2 
cm, 18 (1.8%) of 993 patients with 2~4 cm, and 29 (5.8%) of 498 
patients with 4 cm or more. As the size of the tumor increased, the 
number of metastatic lymph nodes increased, and the differences 
were of statistical significance (P＜0.001) (Table 1). Classified 
according to the location of tumor, the upper stomach cancer was 
found in 144 cases, the middle stomach cancer in 706 cases, the 
lower stomach cancer in 1,675 cases, and lymph node metastasis 
was found in 2 cases (1.4%), 16 cases (2.3%), and 39 cases (2.3%), 
respectively. In the middle and lower stomach, there was a 
higher incidence of lymph node metastasis which was statistically 
significant (P＜0.001).
According to the gross appearance of tumors, they were 
classified as 212 cases of elevated type, 1,011 cases of flat type, 
1,184 cases of depressed type, and mixed type totaled 117 cases. 
Lymph node metastasis was found in 6 cases (2.8%), 23 cases 
(2.3%), 24 cases (2.0%), and 4 cases (3.4%), respectively, but were 
not statistically significant (P=0.725). According to the analysis of 
histological classification, among all of mucosa cancers, no lymph 
node metastasis was shown in 6 cases of papillary adenocarcinoma. Frequency and Predictive Factors of Lymph Node Metastasis in Mucosal Cancer
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It was found in 4 (0.6%) out of 661 cases of all well differentiated 
tubular adenocarcinoma, 7 (0.9%) out of 780 cases of all moderately 
differentiated tubular adenocarcinoma, 23 (6.4%) out of 357 cases 
of all poorly differentiated adenocarcinoma and 23 (3.2%) of 720 
cases of all signet-ring cell carcinoma. It showed that the lymph 
node metastases in poorly differentiated adenocarcinoma and 
signet-ring cell carcinoma have significantly higher incidence 
(P＜0.001). In 57 cases of lymph node positive patients, there 
were 0 (0%) cases in papillary adenocarcinoma, 4 (7%) cases in 
well differentiated tubular adenocarcinoma, 7 (12.1%) cases in 
moderately differentiated tubular adenocarcinoma, 23 (40.4%) cases 
in poorly differentiated tubular adenocarcinoma, and 23 (40.4%) 
cases in signet-ring cell carcinoma. 
According to Lauren’s histological classification, there were 
1,481 cases of intestinal type, 1,010 cases of diffuse type and 33 
cases of mixed type. Lymph node metastasis in each case was 
found in 13 cases (0.9%), 42 cases (4.2%), and 2 cases (6.1%), 
respectively. There was a significantly higher incidence of lymph 
node metastasis in diffuse type (P＜0.001). Lymph node metastasis 
was found in 43 cases among 2,495 patients without lymphatic 
invasion and in 14 cases among 29 patients with lymphatic invasion. 
This demonstrated that lymphatic invasion is a factor influencing 
lymph node metastasis in mucosal cancer (P＜0.001). Lymph 
node metastasis was found in 56 of 2,520 cases without vascular 
invasion and in one of 4 cases with vascular invasion (P=0.087), 
and it was found in 56 of 2,521 cases without perineural invasion, 
and in one of 3 cases with perineural invasion (P=0.066). Based on 
these results, vascular invasion and perineural invasion were not 
statistically significant predictive factors for lymph node metastasis 
in mucosal cancer. 
2. Multivariate analysis of clinicopathological factors 
associated with lymph node metastasis
The multivariate analysis on the five factors found to be 
statistically significant in the univariate analysis, namely the size and 
location of tumor, histologic differentiation, Lauren classification, 
and lymphatic invasion showed that cases of the tumor larger 
than 4cm in size (odds ratio 4.465, 95% confidence interval; 
1.027~19.414, P=0.024) and cases with lymphatic invasion (odds 
ratio 49.662, 95% confidence interval; 20.045~123.039, P＜0.001) 
were correlated independently with lymph node metastasis (Table 2). 
In the univariate analysis, the larger tumor size showed the higher 
incidence of lymph node metastasis, but in multivariate analysis, it 
showed that it is significant as an independent predictive factor of 
Table 1. Relationship between clinicopathological factors and lymph 
node metastasis 
Clinicopathological  
factors
Lymph node 
negative (%)
Lymph node 
positive (%)
P-value
Gender 0.127
    Male 1,585 (98.1) 31 (1.9)
    Female 882 (97.1) 26 (2.9)
Age (years)  54.6±11.7 52.6±11.7 0.207
Tumor size (cm) <0.001
    <1 cm 371 (99.5) 2 (0.5)
    1 cm≤ <2 cm 647 (98.8) 8 (1.2)
    2 cm≤ <4 cm 978 (98.2) 18 (1.8)
    ≥4 cm 471 (94.2) 29 (5.8)
Operation 0.268
    Subtotal 2,223 (97.8) 49 (2.2)
    Total 244 (96.8) 8 (3.2)
Tumor location <0.001
    Upper 1/3 141  (98.6) 2 (1.4)
    Middle 1/3 690  (97.9) 16 (2.3)
    Lower 1/3
Gross fi  nding
    Elevated
    Flat
    Depressed
    Mixed
Histological type
    Papillary
    WD
    MD
    PD
    SRC
Lauren classifi  cation
    Intestinal
    Diff  use
    Mixed
Lymphatic invasion
    Absent
    Present
Vascular invasion
    Absent
    Present
Neural invasion
    Absent
    Present
1,636 (97.7)
206  (97.2)
988  (97.7)
1,160 (98.0)
113  (96.6)
        6 (100.0)
657 (99.4)
773 (99.1)
334 (93.6)
697 (96.8)
1,468 (99.1)
968 (95.8)
31 (93.9)
2,452 (98.3)
15 (51.7)
2,464 (97.8)
3 (75.0)
2,465 (97.8)
2 (66.7)
39 (2.3)
6 (2.8)
23 (2.3)
24 (2.0)
4 (3.4)
0 (0)
4 (0.6)
7 (0.9)
23 (6.4)
23 (3.2)
13 (0.9)
42 (4.2)
2 (6.1)
43 (1.7)
       14 (48.3)
56 (2.2)
         1 (25.0)
56 (2.2)
         1 (33.3)
0.725
<0.001
<0.001
<0.001
0.087
0.066
WD = well differentiated; MD = moderately differentiated; PD = 
poorly diff  erentiated; SRC = signet-ring cell.Nam MJ, et al.
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lymph node metastasis only in the cases of tumor size greater than 
4 cm. The location of the tumor, histologic differentiation (classified 
with differentiated and undifferentiated types) and Lauren 
classification showed no independent correlation with lymph node 
metastasis.
3. Analysis of the frequency of lymph node metas-
tasis according to the tumor size in the patient 
with lymphatic invasion
Among 29 patients with lymphatic invasion, 2 patients had 
tumors with diameter less than 1 cm and lymph node metastasis 
was shown in one (50%) of them. One (33.3%) of 3 patients had 
tumor size of 1~2 cm, and with tumor size of 2~4 cm, 4 (40.0%) 
out of 10 patients presented with positive lymphatic invasion. Two 
(14.2%) of 14 patients had tumor larger than 4 cm in size and also 
presented with lymphatic invasion (Table 3). 
Discussion
Recently worldwide incidence and mortality of gastric cancer 
has been decreasing, but it is remains the fourth most common 
malignant tumor and the second leading cause of cancer deaths.
(11,12) According to the report of cancer incidence from 2003 
to 2005 in Korea, announced by Korea Central Cancer Registry, 
Department of Health and Welfare, gastric cancer is most common 
type with 18.3% of the total cancer incidence in Korea. It is ranked 
first among men and is ranked third with 13.7% following breast 
cancer and thyroid cancer among women. In the past, laparotomy 
was often suggested for radical treatment of gastric cancer, but 
recently minimally invasive treatments by cancer resection have 
been widely conducted with the development of endoscopic surgery 
techniques and equipments as early diagnosis of gastric cancer 
rates are increasing due to the activation of medical examination. 
Unlike radical laparotomy surgery, in particular, by the advantage 
of organ preservation after surgery and the better quality of life 
in patients, endoscopic mucosal resection (EMR) and endoscopic 
submucosal dissection (ESD) are frequently conducted in the 
large medical centers. In early gastric cancer, EMR indications are 
known for elevated lesions of less than 2 cm in size confined to 
the mucosa with mucosal invasion and cancer cell differentiation 
and depressed lesions of less than 1 cm in size without ulcer.(13) 
With the introduction of ESD, treatments by endoscopic resection 
have been also conducted for early stage gastric cancer of less than 
3 cm in size with mucosal invasion of upper third of stomach,(14) 
and in Korea, the complete resection rate in endoscopic resection 
for early gastric cancer is an estimated 75~87%.(15,16) In this 
study, the incidence of lymph node metastasis in mucosal cancer 
was 2.2%, and it showed the same or lower result compared with 
other existing studies showing about 3~5%.(12,17-20) Haruta et 
al.(20) reported that 14 cases (1.9%) among 718 cases of mucosa 
cancer showed lymph node metastasis and ulcers were associated 
with all these cases and mucosal cancer without ulceration showed 
no lymph node metastasis regardless of the size of tumor and 
histologic differentiation. According to previous studies of lymph 
Table 2. Multivariate analysis of potential risk factors for lymph 
node metastasis
Variables Odds  ratio 95% CI P-value
Tumor size (cm)
    <1 cm
    1 cm≤ <2 cm 1.441 0.295~7.030 0.651
    2 cm≤ <4 cm 1.707 0.384~7.594 0.482
    ≥4 cm 4.465 1.027~19.414 0.024
Tumor location
    Upper 1/3
    Middle 1/3 1.054 0.281~3.950 0.938
    Lower 1/3
Histological type
    Diff  erentiated
    Undiff  erentiated
Lauren classifi  cation
    Intestinal
    Diff  use
    Mixed
Lymphatic invasion
    Absent
    Present
1.229
3.878
1.547
1.436
49.662
0.348~4.339
0.872~17.239
0.366~6.534
0.181~11.401
20.045~123.039
0.749
0.075
0.553
0.732
<0.001
95% CI = 95% confi  dence interval.
Table 3. Lymph node metastasis rate assessed by combining 
lymphatic invasion and tumor size in mucosal cancer
Tumor size
Lymphatic invasion (-)
N=2,495, (%)
Lymphatic invasion (+)
N=29, (%)
<1 cm     1/320 (0.3)  1/2 (50.0)
1 cm≤ < 2 cm     7/627 (1.1)  1/3 (33.3)
2 cm≤ <4 cm 20/1,026 (1.9) 4/10 (40.0)
≥4 cm    21/532 (3.9) 2 /14 (14.2)Frequency and Predictive Factors of Lymph Node Metastasis in Mucosal Cancer
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node metastasis, the analysis of various clinicopathological factors 
(age, gender, tumor size and location, gross appearance, histologic 
differentiation, presence of ulceration, lymphatic invasion, etc.) 
showed that age, depressed type, tumor size, undifferentiated type, 
the case associated with ulcer, and the case with lymphatic invasion 
have significant correlations with lymph node metastasis. Among 
these, lymphatic invasion, the case associated with ulcer, and the 
tumor size larger than 3cm were reported as the risk factors in 
predicting lymph node metastasis.(21,22) 
The univariate analysis of our research data showed that the 
factors associated with lymph node metastasis are tumor size, the 
middle and lower third areas of the stomach, poorly differentiated 
adenocarcinoma and signet-ring cell carcinoma, diffuse type by 
Lauren classification, and lymphatic invasion, showing similar 
results consistent with other existing studies.(23,24) The multivariate 
analysis on these factors showed that the independent predictive 
factors associated with lymph node metastasis in mucosal cancer 
are the tumor size (4 cm or more) and lymphatic invasion. Also, 
metastatic frequency analysis according to the tumor size in patients 
with lymphatic invasion showed that a higher frequency of lymph 
node metastasis appears in the cases of lymphatic invasion in 
mucosal cancer with tumor less than 4 cm. A 41 year-old man who 
showed lymphatic invasion in mucosal cancer less than 1cm in size 
was treated with subtotal gastrectomy for type IIc lesions at gastric 
angle. According to the pathological examination results, it was a 
poorly differentiated adenocarcinoma 0.5 cm in size and intestinal 
type according to Lauren classification. He showed no vascular and 
perineural invasion, and no metastasis of cancer among total 59 
retrieved lymph nodes. In the same group a 58 year-old women 
underwent subtotal gastrectomy for mucosal cancer type IIb lesions 
at the low third of stomach, and showed poorly differentiated 
adenocarcinoma of 0.4 cm in size and diffuse type by histologic 
examination. She showed lymphatic invasion and metastasis of 
cancer was found in one of 48 resected lymph nodes. This indicates 
that even if the tumor size was less than 1 cm, in case of lymphatic 
invasion, there was an increase in the incidence of lymph node 
metastasis. This implies that lymphatic invasion in early gastric 
cancer confined to mucosa is the most strong predictive factor 
associated with lymph node metastasis in mucosa cancer. 
Recently, based on the results of surgical data analysis that 
lesions confined to mucosa without ulceration did not show LN 
metastasis regardless of their sizes, there are moves to expand the 
indication for ESD.(9) However, according to the results of this 
study, even lesions confined to mucosa should be treated with 
surgery because the possibility of lymph node metastasis increases 
if their sizes of lesions are larger than 4 cm. 
According to Saka et al.,(25) the overall recurrence rate of early 
gastric cancer is relatively low, between 1.4~2.8%. The recurrence 
rate of early gastric cancer without lymph node metastasis was 
0.6~0.7%, whereas the recurrence rate with lymph node metastasis 
was 7~20%, showing a relatively increased result. Also in the study 
of Han et al., early gastric cancer recurrence in all patients was 2.4%, 
but it tended to have a higher rate of 7.3% in patients with lymph 
node metastasis. This is due to the pathologic characteristics of 
gastric cancer. Even in early gastric cancer, lymph node metastasis 
is a very important prognostic factor, and we presume it will be 
very helpful in determining the treatment strategy of early gastric 
cancer to predict lymph node metastasis. 
Recently, the rate of patients with early gastric cancer among 
the total gastric cancer patients has been increasing. Especially 
in mucosal cancer, endoscopic resection is a widely performed 
procedure, but requires cautious patient selection even in early stage 
gastric cancer since there is a possibility of cancer recurrence in 
the cases with lymph node metastasis. Recently, there are moves 
to expand the target range of conducting ESD, but even for early 
gastric cancer confined to mucosa, ESD should not be conducted 
and it should be treated with surgery because the frequency of 
lymph node metastasis increases when lymphatic invasion is 
present or the tumor size is larger than 4 cm. 
References 
1.  Park CH, Song KY, Kim SN. Treatment results for gastric can-
cer surgery: 12 years' experience at a single institute in Korea. 
Eur J Surg Oncol 2008;34:36-41.
2.  Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph 
node micrometastasis in node negative early gastric cancer. 
Eur J Surg Oncol 2009;35:409-414.
3.  Higashi H, Natsugoe S, Ishigami S, Uenosono Y, Matsumoto 
M, Nakajo A, et al. Distribution of lymph node metastasis 
including micrometastasis in gastric cancer with submucosal 
invasion. World J Surg 2003;27:455-459.
4.  Sano T, Hollowood A. Early gastric cancer: diagnosis and less 
invasive treatments. Scand J Surg 2006;95:249-255.
5.  Seo WH, Seo BJ, Yu HJ, Lee HK, Lee WY. Analysis of prog-
nostic factors in 1,435 surgically treated patients with gastric 
cancer. J Korean Gastric Cancer Assoc 2009;9:143-151.
6.  Kim CH, Jang SW, Kang SH, Kim SW, Song SK. Th  e  signifi  -Nam MJ, et al.
167
cance of lymphatic, venous, and neural invasion as prognostic 
factors in patients with gastric cancer. J  Korean  Gastric Can-
cer Assoc 2005;5:113-119.
7.  An JY, Baik YH, Choi MG, Noh JH, Sohn TS, Kim S. Predic-
tive factors for lymph node metastasis in early gastric cancer 
with submucosal invasion: analysis of a single institutional 
experience. Ann Surg 2007;246:749-753.
8.  Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Tanigu-
chi H, et al. Incidence of lymph node metastasis and the fea-
sibility of endoscopic resection for undiff  erentiated-type early 
gastric cancer. Gastric Cancer 2009;12:148-152.
9.  Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shi-
moda T, et al.  Incidence of lymph node metastasis from early 
gastric cancer: estimation with a large number of cases at two 
large centers. Gastric Cancer 2000;3:219-225.
10.  Japanese Gastric Cancer Association, eds. Japanese Clas-
sification of Gastric Carcinoma. 13th ed. Tokyo: Kanehara, 
1998:10-24.
11.  Brenner H, Rothenbacher D, Arndt V. Epidemiology of stom-
ach cancer. Methods Mol Biol 2009;472:467-477.
12.  Crew KD, Neugut AI. Epidemiology of gastric cancer. World 
J Gastroenterol 2006;12:354-362.
13.  Nakajima T. Gastric cancer treatment guidelines in Japan. 
Gastric Cancer 2002;5:1-5.
14.  Adachi Y, Shiraishi N, Kitano S. Modern treatment of early 
gastric cancer: review of the Japanese experience. Dig Surg 
2002;19:333-339.
15. Lee  JH, Kim JJ. Endoscopic mucosal resection of early gas-
tric cancer: Experiences in Korea. World J Gastroenterol 
2007;13:3657-3661.
16.  Lee JH. Endoscopic resection of early gastric cancer in Korea: 
Recent results and future directions. J  Korean  Gastric Cancer 
Assoc 2009;9:39-45.
17.  Han KB, Jang, YJ, Kim JH, Park SS, Park SH, Kim SJ, et al. 
Factors aff  ecting prognosis in early gastric cancer. J  Korean   
Gastric Cancer Assoc  2009;9:238-245. 
18.  Shimada S, Yagi Y, Shiomori K, Honmyo U, Hayashi N, 
Matsuo A, et al. Characterization of early gastric cancer 
and proposal of the optimal therapeutic strategy. Surgery 
2001;129:714-719.
19.  Torii A, Sakai M, Inoue K, Yamabe H, Ueda S, Okuma M. A 
clinicopathological analysis of early gastric cancer: retrospec-
tive study with special reference to lymph node metastasis. 
Cancer Detect Prev 1994;18:437-441.
20.  Haruta H, Hosoya Y, Sakuma K, Shibusawa H, Satoh K, 
Yamamoto H, et al. Clinicopathological study of lymph-
node metastasis in 1,389 patients with early gastric cancer: 
assessment of indications for endoscopic resection. J Dig Dis 
2008;9:213-218.
21.  Shen L, Huang Y, Sun M, Xu H, Wei W, Wu W. Clinicopatho-
logical features associated with lymph node metastasis in 
early gastric cancer: analysis of a single-institution experience 
in China. Can J Gastroenterol 2009;23:353-356.
22.  Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, 
et al. Risk factors for lymph node metastasis from intramuco-
sal gastric carcinoma. Cancer 1996;77:602-606.
23.  Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, Mura-
ta K, et al.  Lymph node metastasis as a signifi  cant prognostic 
factor in gastric cancer: a multiple logistic regression analysis. 
Scand J Gastroenterol 2004;39:380-384.
24.  Kwak CS, Lee HK, Cho SJ, Yang HK, Lee KU, Choe KJ, et al. 
Analysis of clinicopathological factors associated with lymph 
node metastasis in early gastric cancer; Review of 2,137 cases. 
J Korean Cancer Assoc 2000;32:674-681.
25.  Saka M, Katai H, Fukagawa T, Nijjar R, Sano T. Recurrence in 
early gastric cancer with lymph node metastasis. Gastric Can-
cer 2008;11:214-218.